490 related articles for article (PubMed ID: 19035982)
21. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
22. Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?
Canbakan B; Senturk H; Canbakan M; Toptas T; Tabak O; Balci H; Olgac V; Ozbay G
Biomark Med; 2010 Apr; 4(2):205-14. PubMed ID: 20406065
[TBL] [Abstract][Full Text] [Related]
23. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
24. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
25. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.
Kunde SS; Lazenby AJ; Clements RH; Abrams GA
Hepatology; 2005 Sep; 42(3):650-6. PubMed ID: 16037946
[TBL] [Abstract][Full Text] [Related]
27. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity.
Puljiz Z; Stimac D; Kovac D; Puljiz M; Bratanić A; Kovacić V; Kardum D; Bonacin D; Hozo I
Coll Antropol; 2010 Mar; 34 Suppl 1():33-7. PubMed ID: 20402293
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
[TBL] [Abstract][Full Text] [Related]
29. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
[TBL] [Abstract][Full Text] [Related]
30. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
[TBL] [Abstract][Full Text] [Related]
31. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors.
Pourshams A; Malekzadeh R; Monavvari A; Akbari MR; Mohamadkhani A; Yarahmadi S; Seddighi N; Mohamadnejad M; Sotoudeh M; Madjlessi A
J Gastroenterol Hepatol; 2005 Feb; 20(2):229-33. PubMed ID: 15683425
[TBL] [Abstract][Full Text] [Related]
34. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
37. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS
Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385
[TBL] [Abstract][Full Text] [Related]
38. Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD.
Kotoh K; Nakamuta M; Fukushima M; Morizono S; Enjoji M; Nawata H
Hepatogastroenterology; 2007; 54(73):224-8. PubMed ID: 17419265
[TBL] [Abstract][Full Text] [Related]
39. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
Wong VW; Chan HL; Hui AY; Chan KF; Liew CT; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2004 Jul; 20(1):45-9. PubMed ID: 15225170
[TBL] [Abstract][Full Text] [Related]
40. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]